Wang, Hongbiao
Wang, Zhao
Zhu, Sujuan
Li, Zhifeng
Yang, Hang
Sun, Peng
Zhu, Minyi
Zhao, Xiaotian
Shen, Lu
Ou, Qiuxiang
Yang, Hui
Li, Zhi-Ming
Funding for this research was provided by:
Medical Science and Technology Foundation of Guangdong Province (A202142)
National Natural Science Foundation of China (nos.81872902, 82073917)
National Natural Science Foundation of Guangdong Province (2023A1515011525)
Lymphoma Research Fund of China Anti-Cancer Association and the Sun Yat-sen University Cancer Center Clinical Research 308 Program (nos. 2014-fxy-106 and 2016-fxy-079)
Article History
Received: 5 February 2024
Accepted: 24 April 2024
First Online: 16 July 2024
Declarations
:
: M Zhu, X Zhao, L Shen, and Q Ou are employees of Nanjing Geneseeq Technology Inc., China. The remaining authors have nothing to disclose.
: This study was approved by Ethics Committee of the Cancer Hospital of Shantou University Medical College (No. 2023059). All patients signed informed consent forms prior to enrollment and sample collection.
: M Zhu, X Zhao, L Shen, and Q Ou are employees of Nanjing Geneseeq Technology Inc., China. The remaining authors have nothing to disclose.